Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
01/2004
01/29/2004US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
01/28/2004EP1383739A1 New compounds
01/28/2004CN1471509A 9-substituted minocycline compounds
01/27/2004US6683198 Group(III)-metal-hydrides with a guanidino-type ligand
01/22/2004US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides
01/21/2004EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria
01/20/2004US6680408 Reacting s-methyl nitroisothiourea with alpha-ethylbenzylamine in the presence of water and ethanol mixtures to form 1-(alpha-ethylbenzyl)-3-nitroguanidine, used as preemergence herbicides
01/15/2004WO2004005422A1 Ultraviolet-absorbing composition
01/15/2004US20040009140 Cosmetics 1-isostearylglycerol-3-Sulfate Sodium Salt, used for constriction of keratinocytes; aging resistance
01/14/2004CN1467204A Method for preparing motherwort total alkaloid and new medicine uses
01/13/2004CA2076664C Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
01/08/2004WO2004002944A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002940A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2003093302A3 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004CA2491156A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2490950A1 Inhibitors of hcv ns5b polymerase
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto
01/06/2004US6673557 Methods of treatment of eye trauma and disorders
01/06/2004CA2098472C Contact lens care product for hard and soft contact lenses
01/02/2004EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
12/2003
12/30/2003US6670344 Having greater solubility than native combretastatin A-4, and rapidly regenerate combretastatin A-4 under physiological conditions; for use in cancer therapy
12/30/2003US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group
12/30/2003US6669739 Agent for coloring fibers and method for temporarily coloring fibers
12/25/2003US20030236168 Providing a reaction mixture comprising water, alcohol, an S-alkyl nitroisothiourea, and an alpha -substituted benzylamine compound; heating; steam distillation; isolating an alpha -substituted benzylnitroguanidine from water layer
12/24/2003WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
12/24/2003CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament
12/23/2003CA2208032C Substituted amidinonaphthyl ester derivative
12/18/2003WO2003103722A1 New agents for magnetic imaging method
12/18/2003WO2003033437A3 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained
12/18/2003WO2003024407A3 Inhibitors of rnase p proteins as antibacterial compounds
12/18/2003US20030232789 Salicylamides as serine protease and factor xa inhibitors
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP0865434B1 Compounds and their use to treat infectious diseases
12/17/2003CN1131208C Compound, their preparation and use for transferring nucleic acids into cells
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664294 Compounds which have excellent antimicrobial activity, even at very low concentrations, and which is retained in presence of salt-containing media, such as saline solutions
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/10/2003EP1369134A1 New agents for magnetic imaging method
12/04/2003WO2003099806A1 Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same
12/04/2003WO2003066673A8 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/03/2003EP1366022A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003EP1366017A2 Non-natural basic amino acids, their preparation and use
12/03/2003CN1460102A Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
12/02/2003US6656498 Cationic liposomes for gene transfer
11/2003
11/27/2003US20030220301 Metformin salts of lipophilic acids
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/26/2003EP1021099B1 Anti-bacterial amine derivatives
11/25/2003US6653504 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/20/2003WO2003095421A1 Amino acid analogues
11/19/2003EP1363345A2 Guanidine derivatives as cations for ambient temperature molten salts in electrochemical power sources
11/19/2003CN1456548A Process for extracting leonuridine from fresh motherwort and leonuridine preparation
11/18/2003US6649613 Diacylhydrazine derivatives
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030211389 Guanidine derivatives as cations for ambient temperature molten salts in electrochemical power sources
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6645968 Potassium channel openers
11/09/2003CA2428420A1 Guanidine derivatives as cations for ambient temperature molten salts in electrochemical power sources
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003US20030207908 Systemically and topically treat bacterial Gram-positive, Gram-negative and anaerobic infections, specially resistant Gram-positive mycobacterial infections and emerging nosocomlal pathogen infections
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207823 Novel diabetes imaging probes
11/05/2003EP1037882B1 Substituted 2,4-diamino-1,3,5-triazines
10/2003
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030203908 A triazine enzyme inhibitors for treating malaria, parasite disease, Chagas' disease, sleep disorder or Toxoplasma goudii; chemical intermediate synthesis
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2002081483A3 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/23/2003US20030199499 Novel guanidinobenzamides
10/22/2003EP1353902A2 Inhibitors of serine protease activity of matriptase or mtsp1
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1140803B1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/16/2003WO2003084820A2 Method for protecting packed food products from spoilage during storage and package or pre-cut package for storing food products
10/15/2003EP1202995B1 Group(iii)-metal-hydrides with a guanidino-type ligand
10/15/2003EP1007096B1 Arginine silicate inositol complex and use thereof
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/09/2003WO2003014076A3 Bi-directional synthesis of oligoguanidine transport agents
10/08/2003EP1349578A2 Medicinal association of a biguanine (metformin) and arginine
10/08/2003CN1446804A Compound possessing fungicidal property and its usage
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
09/2003
09/30/2003US6627769 Antiproliferative agents
09/25/2003US20030181424 Compositions with vascular damaging activity
09/25/2003US20030180276 Nutrient, foods
09/24/2003EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003US20030176607 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 54